Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction on Monday, November 9th. The shares were sold at an average price of $385.63, for a total transaction of $539,882.00. Following the completion of the sale, the executive vice president directly owned 625 shares
Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP Courtney Enloe sold 902 shares of the company's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $386.17, for a total value of $348,325.34. Following the sale, the executive vice president owned 750 shares in the company, valued
Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) COO Jonathan Divincenzo sold 919 shares of the stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $390.47, for a total transaction of $358,841.93. Following the sale, the chief operating officer directly owned 1,962 shares of the
Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) EVP James Barry sold 1,400 shares of the company's stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $385.63, for a total value of $539,882.00. Following the completion of the transaction, the executive vice president owned 625 shares of
Fisher Asset Management LLC lessened its position in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 114,719 shares of the medical research company's stock after selling 2,190 shares during the quarter. Fisher Asset
HOLMDEL, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced its third quarter (Q3'26) and nine-month (9M'26) results for the period ended September 30, 2026.
KUALA LUMPUR, MALAYSIA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update.
BIO-key entered gaming & hospitality market with contract from major U.S. casino resort to deploy PortalGuard® IAM platform and Identity-Bound Biometrics.
Bio-Rad Laboratories, Inc. ( BIO ) 2026 UBS Global Healthcare Conference November 10, 2026 8:00 AM EST Company Participants Roop Lakkaraju - Executive VP & CFO Conference Call Participants Douglas Schenkel - UBS Investment Bank, Research Division Presentation Douglas Schenkel UBS Investment Bank, Research Division Welcome Roop Lakkaraju, EVP and Chief Financial Officer of Bio-Rad. Roop, thank you for being here this morning.
Dyadic Applied BioSolutions, BRIG BIO and Strive Nutrition Announce a Strategic Collaboration to Accelerate the Commercialization of Precision-Fermented Al